SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-21-013185
Filing Date
2021-03-15
Accepted
2021-03-15 16:53:50
Documents
4
Effectiveness Date
2021-03-15

Document Format Files

Seq Description Document Type Size
1 S-8 ngm-s8.htm S-8 138394
2 EX-5.1 ngm-ex51_7.htm EX-5.1 10706
3 EX-23.2 ngm-ex232_6.htm EX-23.2 3124
4 GRAPHIC gynscxhrkzoe000001.jpg GRAPHIC 10499
  Complete submission text file 0001564590-21-013185.txt   167845
Mailing Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-243-5555
NGM BIOPHARMACEUTICALS INC (Filer) CIK: 0001426332 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-254295 | Film No.: 21742155
SIC: 2834 Pharmaceutical Preparations